Experience Helped San Diego’s EHS Get First FDA-Approved Wireless Blood Glucose Meter

(Page 3 of 3)

regulatory approval in Europe also made it easier to win FDA approval in the U.S. “It wasn’t a conscious decision,” Strobridge said, “but it ended up being easier.”

The expertise and experience of Entra Health’s co-founders also helped. Hendel, who had previously worked in Europe for two years with a telephone communications services company, had contacts with UK Trade & Investment that led to a major consulting project in England for Entra Health’s founders. The work generated early revenue for the startup, and enabled the company to begin working immediately with European regulators.

Entra Health also serves as an example of the type of wireless health startups that are taking root in San Diego, and helps to explain why San Diego is emerging as an innovation hub for mobile health.

The three co-founders have self-funded the company, as Strobridge put it, “to not give up a lot of equity and get as far down the road as we can with regulatory clearances and worldwide distribution.”

In the past year or so, Entra Health also introduced its “MyGlucoHealth Wireless” technology in Australia, Hong Kong, and South Korea. The company now has a global workforce of about 20 employees, prompting Strobridge to quip, “We’re the smallest multi-national company that I know.”

Strobridge adds, “Our strategy is to stay out front with our product road map [for MyGlucoHealth] and with the development of other products that help manage chronic diseases.”

For example, Entra Health has developed a wireless hub device for its MyGlucoHealth Wireless technology that can support several blood glucose meters simultaneously. The company also created TouchTrak, a patient management system for hospitals and healthcare practices that enables patients to check-in at a free-standing touch-screen computer display that asks a series of questions about the patient.

Strobridge says the company also has been doing a lot of work to identify potential strategic partners, and has been in discussions with others.

“A lot of non-traditional healthcare providers are quite interested in [MyGlucoHealth], and in seeing how it will play out,” he says.

Single PageCurrently on Page: 1 2 3 previous page

Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at bbigelow@xconomy.com or call (619) 669-8788 Follow @bvbigelow

Trending on Xconomy